BP000134-C006: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less then 0.2 ug/ml, corresponding to a Specific Activity of 8.0 x 106 IU/ mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000134-CYT-013: Recombinant Human Interleukin-11 (IL-11) Protein, Pichia
Source: Pichia Pastoris-derived..
The ED50 as determined by the dose-dependent stimulation of the proliferation of murine 7TD1 was found to be less then 0.2 ug/ml, corresponding to a Specific Activity of1,000,000 IU/ mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000134-CYT-214: Recombinant Human Interleukin-11 (IL-11) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be < 10ng/ml, corresponding to a Specific Activity of 100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000134-CYT-646: Recombinant Mouse Interleukin-11 (IL-11) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of mouse 7TD1 was found to be less then 1.5 ng/ml, corresponding to a specific activity of 666666.66 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000134-GD21: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less than 0.2 ng/ml, corresponding to a Specific Activity of 8.0 x 10^6 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000134-GD21: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less than 0.2 ng/ml, corresponding to a Specific Activity of 8.0 x 10^6 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).